Navigating adalimumab biosimilars: an expert opinion by Vered Abitbol, Salim Benkhalifa, Caroline Habauzit, Hubert Marotte

Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cells. by Emily Loison, Béatrice Poirier-Beaudouin, Valérie Seffer, Audrey Paoletti, Vered Abitbol, Eric Tartour, Odile Launay, Marie-Lise Gougeon

Get full text

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study by Aurelien Amiot, Anne Bourrier, Jean-Marc Gornet, Olivier Dewit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Charlotte Gagnière, Anthony Buisson, Maria Nachury, Stephanie Viennot, Lucine Vuitton, Carmen Stefanescu, Philippe Marteau, Guillaume Bouguen, Philippe Seksik

Get full text

Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Bénédicte Caron, Philippe Seksik, Anthony Buisson, Pauline Wils, Guillaume Savoye, Carmen Stefanescu, David Laharie, Lucas Guillo, Vered Abitbol, Joelle Bonnet, Romain Altwegg, Lucine Vuitton, Driffa Moussata, Arnaud Bourreille, Amélie Biron, Cyrielle Gilletta, Mathurin Fumery, Stephane Nahon, Stephane Nancey, Houda Camara, Laurent Peyrin-Biroulet

Get full text